Annual Shareholders Equity
$112.22 M
-$18.94 M-14.44%
31 December 2021
Summary:
Concert Pharmaceuticals annual stockholders equity is currently $112.22 million, with the most recent change of -$18.94 million (-14.44%) on 31 December 2021. During the last 3 years, it has fallen by -$18.94 million (-14.44%).CNCE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$133.27 M
+$5.48 M+4.29%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly stockholders equity is currently $133.27 million, with the most recent change of +$5.48 million (+4.29%) on 30 September 2022.CNCE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -14.4% | +34.4% |
| 5 y5 years | -33.1% | +11.8% |
CNCE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -42.9% | -36.7% |
Concert Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $133.27 M(+4.3%) |
| June 2022 | - | $127.79 M(+66.9%) |
| Mar 2022 | - | $76.57 M(-31.8%) |
| Dec 2021 | $112.22 M(-14.4%) | $112.22 M(+13.2%) |
| Sept 2021 | - | $99.16 M(-19.2%) |
| June 2021 | - | $122.72 M(+7.6%) |
| Mar 2021 | - | $114.04 M(-13.1%) |
| Dec 2020 | $131.16 M(+29.3%) | $131.16 M(+2.5%) |
| Sept 2020 | - | $127.94 M(-11.2%) |
| June 2020 | - | $144.09 M(-6.7%) |
| Mar 2020 | - | $154.48 M(+52.3%) |
| Dec 2019 | $101.46 M(-39.5%) | $101.46 M(-14.9%) |
| Sept 2019 | - | $119.26 M(-10.8%) |
| June 2019 | - | $133.70 M(-10.7%) |
| Mar 2019 | - | $149.80 M(-10.7%) |
| Dec 2018 | $167.74 M(-14.6%) | $167.74 M(-9.7%) |
| Sept 2018 | - | $185.75 M(-7.3%) |
| June 2018 | - | $200.28 M(-4.8%) |
| Mar 2018 | - | $210.40 M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $196.43 M(+129.5%) | $196.43 M(+0.3%) |
| Sept 2017 | - | $195.86 M(+204.2%) |
| June 2017 | - | $64.38 M(-14.2%) |
| Mar 2017 | - | $75.02 M(-12.4%) |
| Dec 2016 | $85.59 M(-34.5%) | $85.59 M(-11.0%) |
| Sept 2016 | - | $96.14 M(-9.5%) |
| June 2016 | - | $106.18 M(-10.2%) |
| Mar 2016 | - | $118.26 M(-9.5%) |
| Dec 2015 | $130.63 M(+138.3%) | $130.63 M(+1.4%) |
| Sept 2015 | - | $128.87 M(-5.1%) |
| June 2015 | - | $135.74 M(+45.2%) |
| Mar 2015 | - | $93.49 M(+70.5%) |
| Dec 2014 | $54.83 M(-148.9%) | $54.83 M(-13.0%) |
| Sept 2014 | - | $63.00 M(-9.6%) |
| June 2014 | - | $69.70 M(-9.7%) |
| Mar 2014 | - | $77.20 M(-168.9%) |
| Dec 2013 | -$112.10 M(+5.1%) | -$112.10 M(-1872.4%) |
| Sept 2013 | - | $6.33 M(-105.9%) |
| Dec 2012 | -$106.69 M(+23.0%) | -$106.69 M |
| Dec 2011 | -$86.72 M | - |
FAQ
- What is Concert Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CNCE is $112.22 M
What is the all time high annual shareholders equity for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual stockholders equity is $196.43 M
What is Concert Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CNCE is $133.27 M
What is the all time high quarterly shareholders equity for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly stockholders equity is $210.40 M